ArticleJournal of nutritional science2015

Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial.

Jun-Ichi Minami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.